954
Views
11
CrossRef citations to date
0
Altmetric
ARTICLES

Diffusion and Diversion of Suboxone: An Exploration of Illicit Street Opioid Selling

, PhD

REFERENCES

  • Furst RT. Suboxone misuse along the opiate maintenance treatment pathway. J Addict Dis 2013; 32:53–67.
  • Daniulaityte R, Falck R, Carlson RG. Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids. Drug Alcohol Depend 2012; 122:201–7.
  • Harman JG, Limbird LE, Gilman AG (Eds). Goodman & Gilman's the pharmalogical basis of therapeutics. 10 ed. New York: McGraw-Hill, 1974.
  • Chiang CN, Hawks RL. Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend 2003; 70:S39–S47.
  • Sontag D. Addiction treatment with a dark side. New York Times. November 17, 2013:A1.
  • Office of Diversion Control. National forensic laboratory information system special report: methadone and buprenorphine, 2003-2008. Washington DC: U.S. Drug Enforcement Administration, 2009. http://tinyurl.com/mc4xxg6 (accessed November 1, 2013).
  • Center for Substance Abuse Research. Thus far in 2012 more than one-half of U.S. states have had media reports of buprenorphine misuse or diversion. CESAR Fax 2012; 21(38):1–2.
  • Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioids pain relievers – Unites States, 2002-2004 and 2008-2010. Drug Alcohol Depend 2013; 132:95–100. doi: 10.1016/j.drugalcdep.2013.01.007.
  • Faupel CE. Shooting dope: career patterns of hard-core heroin users. Gainsville, FL: University of Florida Press, 1991.
  • Center for Substance Abuse Research. High school seniors who misuse prescription narcotics most likely to obtain drugs from a friend/relative or a personal prescription. CESAR Fax 2012; 21:1.
  • The Centers for Disease Control and Prevention (CDC). New CDC vital signs: prescription painkillers epidemic among women. http://www.cdc.gov/media/dpk/2013/dpk_Prescription%drug%20 overdose.HTML (accessed September 20, 2013).
  • Tavernise S. Sharp rise in women's deaths from overdose of painkillers. New York Times. July 3, 2013:A1.
  • Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010; 363:1981–5.
  • Cicero TJ, Inciardi JA. Potential for abuse of buprenorphine in office-based treatment of opioid dependence. N Engl J Med 2005; 353:1863–5.
  • Wish ED, Artigiani E, Billing A, et al. The emerging buprenorphine epidemic in the United States. J Addict Dis 2012; 31:3–7.
  • Katz E, Levin ML, Hamilton H. Traditions of research on the diffusion of innovation. Am Sociol Rev 1963; 28:237–52.
  • Oldenburg BF, Hardcastle DM, Kok G. Diffusion of innovations. In Glanz K, Lewis FM, Rimer B, eds. Health behavior and health education: theory, research and practice, 2nd ed. San Francisco, CA: Jossey-Bass, 1997:270–86.
  • Steinman KJ. Drug selling among high school students: related risk behaviors and psychosocial characteristics. J Adolesc Health 2005; 36:71.e1–71.e8.
  • Rogers EM. Diffusion of innovations. 3rd ed. New York: The Free Press, 1983.
  • Gladwell M. The tipping point: how little things can make a big difference. Boston, MA: Little Brown and Company, 2000.
  • Furst RT, Herrmann C, Leung R, Galea J, Hunt K. Heroin diffusion in the mid-Hudson region of New York State. Addiction 2004; 99:431–41.
  • Cambell ND, Lovell AM. The history of the development of buprenorphine as an addiction therapeutic. Ann NY Acad Sci 2012; 1248:124–39.
  • Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat 2005; 28:321–9.
  • Agar M, Bourgois P, French J, Murdoch O. Buprenorphine: “field trials” of a new drug. Qual Health Res 2001; 11:69–84.
  • Smith RB, Watkins TD. A study of addicts’ career experiences with methadone. Am J Drug Alcohol Abuse 1976; 3:255–65.
  • Ompad DC, Fuller CM, Chan CA, Frye V, Vlahov D, Galea S. Correlates of illicit methadone use in New York City: a cross-sectional study. BMC Public Health, 2008; 8:375. doi: 10.1186/1471-2458-8-375.
  • Centers for Disease Control and Prevention. Policy impact: prescription painkiller overdoses. Atlanta, GA: CDC, 2013. http://www.cdc.gov/homeandrecreationalsafety/rxbrief/ (accessed November 1, 2013).
  • White WL. Pathways from the culture of addiction to the culture of recovery. 2nd ed. Center City, MN: Hazelden, 1996.
  • Campo-Flores A, Elinson Z. Heroin use, and deaths, rise. The Wall Street Journal. February 3, 2014:A5.
  • Potter JS, Marino EN, Hillhouse MP, et al. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). J Stud Alcohol Drugs 2013; 74:605–13.
  • Hser YI, Hoffman V, Grella CE, Anglin MD. A 33 year follow-up of narcotic addicts. Arch Gen Psychiatry 2001; 58:503–8.
  • Waldorf D. Careers in dope. Englewood Cliffs, NJ: Prentice Hall, 1973.
  • Faupel CE. Shooting dope: career patterns of hard-core heroin users. Gainesville, FL: University of Florida Press, 1991.
  • Winick C. Maturing out of narcotic addiction. Bull Narc 1962; 14:1–7.
  • DeFleur LB, Ball JC, Snarr RW. The long-term social correlates of opiate addiction. Soc Probl 1969; 17:225–34.
  • Ferrence R. Diffusion theory and drug use. Addiction 2001; 96:165–73.
  • Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse 2006; 41:255–64.
  • Natarajan MR, Clarke RV, Johnson BD. Telephones as facilitators of drug dealing. Eur J Crim Pol Res 1995; 3:137–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.